Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

10.53
Delayed Data
As of Jun 30
 -0.10 / -0.94%
Today’s Change
6.36
Today|||52-Week Range
18.41
-0.09%
Year-to-Date

Today’s Trading

Previous close10.63
Today’s open10.67
Day’s range10.23 - 10.78
Volume1,161,488
Average volume (3 months)681,463
Market cap$1.2B
Dividend yield9.50%
Data as of 4:00pm ET, 06/30/2016

Growth & Valuation

Earnings growth (last year)+89.33%
Earnings growth (this year)+438.75%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+247.57%
P/E ratioNM
Price/Sales17.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...+0.63+2.59%
ACORAcorda Therapeutics ...+0.11+0.45%
PRTAProthena Corporation...-1.79-4.87%
EBSEmergent BioSolution...-0.05-0.18%
Data as of 4:02pm ET, 06/30/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.11
Annual revenue (last year)$67.8M
Annual profit (last year)-$18.8M
Net profit margin-27.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs